About QuidelOrtho Corporation - Common Stock (QDEL)
QuidelOrtho Corp is a prominent player in the field of medical diagnostics, specializing in the development and manufacture of diagnostic testing solutions. The company focuses on producing innovative products that aid in the rapid detection of infectious diseases and other critical health conditions, utilizing advanced technologies such as molecular diagnostics and immunoassay platforms. QuidelOrtho's portfolio includes a range of tests designed for use in various healthcare settings, including hospitals, laboratories, and physician offices, facilitating timely and accurate diagnoses that enhance patient care. Through its commitment to innovation and quality, the company strives to improve the health outcomes of individuals around the globe. Read More
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 10.5% year on year to $61...
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Tuesday after market hours. Here’s what you need to know. QuidelOrth...
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t...
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Over the past six months, QuidelOrtho’s shares (currently trading at $22.11) have posted a disappointing 19.9% loss, well below the S&P 500’s 6.6% gain. This...
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to 150 days. The rapid reimposition of trade barriers creates significant uncertainty for companies across multiple sectors that depend on international supply chains and global trade. Investors are now weighing the potential impact of these new duties on corporate earnings and broader economic activity.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
